Ellogon.AI assists medical experts in selecting the right patient for cancer immunotherapy. We do this by fast and accurate quantification of relevant biomarkers by use of a breakthrough deep learning approach, developed together with the Netherlands Cancer Institute (NKI). Our CE certified solution EIDOSTM is fully integrated into existing medical treatment protocols.
Our Unique Features
Artificial Intelligence will be of great value in the pathology workflow by optimizing the selection process of patients who will possibly benefit from immunotherapy
Hugo Horlings, pathologist at NKI
Would you like to see a demo?
Interested to get to know more about our solution? Submit your email and we will contact you for a demo!
KWF grant together with Amsterdam UMC, NKI and UvA12 January 2023
KWF grant together with Amsterdam UMC, NKI and UvA 12 January 2023 Jessica We are happy to announce that Ellogon.AI has received a KWF grant together with the Amsterdam UMC,…
EIDOS runs on UbiOps29 December 2022
EIDOS runs on UbiOps 29 December 2022 Jessica Hot off the press! Working with the Netherlands Cancer Institute, Ellogon.AI has developed a faster and more efficient method of…
European Network of AI Excellence Centres (ELISE) 1st open call8 August 2022
Interview of co-founder Efstratios Gavves by ELISE
WeakSTIL: Weak whole-slide image level stromal tumor infiltrating lymphocyte scores are all you need4 April 2022
Scientific publication by Yoni Schirris, PhD student of the HISTO-AI project.